Minotaur Capital, with just three staff, has created a system that lets it rapidly scan potential investment candidates from ...
All details in this article are correct as of October 7, 2025. Accessibility to some of the latest Excel features depends on ...
One of the keys to enterprise customers realizing a return on their investment in AI is the creation of intelligent agents ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...